
Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist for advanced metabolic support and body composition.
Retatrutide
Retatrutide is a novel triple receptor agonist targeting the GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GCGR) simultaneously. This triple agonism represents the frontier of metabolic wellness, combining the complementary effects of three distinct receptor systems to produce metabolic outcomes that exceed those achievable with dual or single receptor agonism.
How It Works
Retatrutide's triple receptor agonism engages three complementary metabolic pathways:
**GLP-1 Receptor Activation:**
• Stimulates glucose-dependent insulin secretion, suppresses glucagon, delays gastric emptying, and activates central satiety circuits
**GIP Receptor Activation:**
• Stimulates glucose-dependent insulin secretion through complementary cAMP pathways, modulates adipocyte lipid metabolism, and contributes to central appetite regulation
**Glucagon Receptor Activation:**
• Promotes lipolysis in adipose tissue and increases energy expenditure through thermogenic mechanisms — balanced by the insulin-stimulating effects of GLP-1R and GIPR co-activation
**Synergistic Triple Agonism:**
• Simultaneous activation of all three receptors produces greater energy expenditure, enhanced fat oxidation, and more pronounced body composition effects than dual agonism
Key Benefits
• Advanced Weight Management:: Triple receptor agonism for superior metabolic effects
• Enhanced Energy Expenditure:: Glucagon receptor activation increases thermogenesis and energy expenditure
• Fat Oxidation:: Enhanced fat burning through complementary receptor pathways
• Body Composition:: Comprehensive support for favorable changes in fat mass and lean mass
Structural Properties
Retatrutide has an approximate molecular weight of 5000 Da. Purity ≥97.0%.
Quality and Purity
Supplied as a lyophilized powder with purity ≥97.0% verified by HPLC and mass spectrometry. Each vial contains 5 mg.
Storage
Store at −80°C. Single-use aliquots required. Stable for 12 months.
Product Details
Storage & Handling
Store at -80°C. Single-use aliquots required.
Related Products

Cagrilintide
Long-acting amylin analogue supporting appetite regulation and metabolic balance.

Orforglipron (Research)
Non-peptide oral GLP-1 receptor agonist for advanced metabolic wellness.